Stroke reduction in hypertensive adults with cardiac hypertrophy randomized to losartan versus atenolol: The Losartan Intervention for Endpoint reduction in hypertension study

Jorge R. Kizer, Björn Dahlöf, Sverre E. Kjeldsen, Stevo Julius, Gareth Beevers, Ulf De Faire, Frej Fyhrquist, Hans Ibsen, Krister Kristianson, Ole Lederballe-Pedersen, Lars H. Lindholm, Markka S. Nieminen, Per Omvik, Suzanne Oparil, Hans Wedel, Kristian Wachtell, Jonathan M. Edelman, Steven M. Snapinn, Katherine E. Harris, Richard B. Devereux

Research output: Contribution to journal › Article › peer-review

83 Scopus citations

Fingerprint

Dive into the research topics of 'Stroke reduction in hypertensive adults with cardiac hypertrophy randomized to losartan versus atenolol: The Losartan Intervention for Endpoint reduction in hypertension study'. Together they form a unique fingerprint.

Medicine & Life Sciences